Client Archives: Novartis

Webinar: Capturing Intangible Risks of Global Trends

  Novartis and SustainAbility presented a webinar on September 11th, the fourth of a series of conversations about the results and outcomes of Novartis’ 2017 Corporate Responsibility Materiality Assessment. In 2018, we began a webinar series with Novartis to showcase and discuss how to manage the impact of a company on society and the environment

Webinar: Evaluating Social Materiality by Measuring Outcomes

  Novartis and SustainAbility presented a webinar on March 12th, the third of a series of conversations about the results and outcomes of Novartis’ 2017 Corporate Responsibility Materiality Assessment. This webinar focused on the measurement & evaluation (M&E) of social outcomes of new business models and healthcare systems. The webinar also explored how Novartis M&E work enables

Webinar: Monetizing Impact Dimensions of Material Issue Areas

  Novartis and SustainAbility presented a webinar on November 27th, the second of a series of conversations about the results and outcomes of Novartis’ 2017 Corporate Responsibility Materiality Assessment. On this webinar speakers shared Novartis’ current approach to quantifying and monetizing impact dimensions of their corporate responsibility material issue areas. John Elkington, Chair of the Impact Valuation

Webinar: What Strategic Value Can Materiality Assessments Deliver in the Future?

  Novartis and SustainAbility presented a webinar on August 17th which kicked-off a series of conversations about the results and outcomes of Novartis’ 2017 Corporate Responsibility Materiality Assessment. This webinar focused on the overall results which highlighted crucial insights into the expectations of Novartis’ stakeholders. Hear from Rob Cameron, Chief Executive at SustainAbility, Michael Fürst, CR

The Maturing of Materiality Really Matters

After 15 years, it might finally be time that materiality fulfils its true potential in driving change towards sustainability. Here’s how. Back in 2003, Simon Zadek, and colleagues were smart enough to recognise that normative standards could accelerate progress on sustainability. That thinking led to the emergence of the AA1000 Assurance Standard with three principles

Integrating Corporate Responsibility into the Core Business Through Materiality

The 2017 Corporate Responsibility Materiality Assessment Results Report summarises the approach and results of the Novartis 2017 corporate responsibility (CR) materiality assessment. This third full materiality assessment for Novartis plays an important role in strengthening the integration of CR in Novartis’ core business. The objectives of the materiality assessment were to: Further align strategies with

Spotlight on Novartis

Launched in 2015, the Novartis Access is a prime example of how the private, public and civic sectors can complement each other. The company is partnering with governments and NGOs to distribute medicines on the ground and to raise awareness and strengthen healthcare system capabilities. Michael Fuerst, Senior Manager Corporate Responsibility Strategy & Innovation at

How Novartis Focussed on Stakeholder Engagement

Global healthcare leader Novartis asked SustainAbility to help it refocus its stakeholder engagement activity. Over a number of years, Novartis and its business divisions had developed a wide range of stakeholder engagement efforts including partnerships such as the Malaria Initiative, expert consultations on material issues, and dialogues through the Novartis Foundation for Sustainable Development. Having